Navigation Links
China Medicine Corporation to Present at Brean Murray Carret & Co. Mainland China Investor Tour
Date:3/31/2008

GUANGZHOU, China, March 31 /Xinhua-PRNewswire/ -- China Medicine Corporation (OTC Bulletin Board: CHME; "China Medicine" or "the Company"), a leading distributor and developer of prescription and over-the-counter pharmaceuticals, traditional Chinese medicines (TCM), nutritional and dietary supplements, medical devices, and medical formulations in the PRC, today announced that the Company will present at the upcoming Brean Murray Carret & Co. Mainland China Investor Tour of China on Thursday April 3, 2008 at Marco Polo Hotel in Shenzhen, China.

Mr. Yang Senshan, China Medicine's Chairman and CEO, will present the overview of the Company's main business, product lines, facilities, competitive strengths, and growth strategies at 9:45 am local time.

For more information about the conference, please visit http://www.breanmurraycarret.com .

About China Medicine Corporation

China Medicine Corporation is a leading pharmaceutical company which discovers and develops medical formulations and distributes over 2,200 pharmaceutical products in China including prescription and over-the-counter ("OTC") drugs, traditional Chinese medicine products, herbs and dietary supplements. The Company distributes the products to wholesale distributors in 28 provinces, more than 300 hospitals, 500 medicine companies, and 1,788 drug stores throughout China. The Company actively develops a number of proprietary products for many uses including oncology, high blood pressure and the removal of toxins from food and animal feeds. For more information visit the Company's website at http://www.chinamedicinecorp.com .

Cautionary Statement

This press release contains forward-looking statements concerning the Company's business and products. The Company's actual results may differ materially depending on a number of risk factors including, but not limited to, the following: general economic and business conditions, obtaining regulatory approval for new products, the expected contribution of higher margin products, government support for rural health care, competition from existing and new competitors, changes in technology, and various other factors beyond its control. All forward-looking statements are expressly qualified in their entirety by this Cautionary Statement and the risk factors detailed in the Company's reports filed with the Securities and Exchange Commission. China Medicine Corporation undertakes no duty to revise or update any forward- looking statements to reflect events or circumstances after the date of this release.

For more information, please contact:

CCG Elite Investor Relations Inc.

Mr. Crocker Coulson, President

Tel: +1-646-213-1915 (New York)

Email: crocker.coulson@ccgir.com

China Medicine Corp

Ms. Huizhen Yu, CFO

Tel: +86-20-8739-1718

Email: konzern08@168.com


'/>"/>
SOURCE China Medicine Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. China Yingxia International, Inc. Announces Record Fourth Quarter and Year 2007 Results
2. China Yingxia International Announces Soybean Milk Production Lines Acquisition
3. Cells from the Research Institute of the MUHC on the road to China
4. China Medicine Announces Record Fourth Quarter and Fiscal Year 2007 Results
5. China Yingxia International Announces 2007 Fourth Quarter and Full Year Financial Results Conference Call
6. China Medicine Announces Conference Call to Discuss Fourth Quarter and Fiscal Year 2007 Results
7. China RuiTai International Holdings Retains CCG Elite for Investor Relations Services
8. China Medical Technologies Receives CE Mark for Two ECLIA Analyzers and 15 Reagents
9. Sinovac to Present at the Brean Murray, Carret & Co. Fourth Investor Tour of China
10. China Nepstar Chain Drugstore Announces Dividend
11. Alsius Corporation Receives Regulatory Approval in China and Mexico
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... (PRWEB) , ... May 27, 2016 , ... Two director-level ... as YWCA Tribute to Women and Industry (TWIN) 2016 honorees. The award recognizes ... workplace. For this year, Geri Boone, Director of the MLTSS (Managed Long-Term Services and ...
(Date:5/27/2016)... New York, NY (PRWEB) , ... May 27, 2016 , ... ... or needing intervention to walk, the demand for a sustainable product to aid in ... this void and aid in the recovery of individuals with hemiplegia due to stroke. ...
(Date:5/27/2016)... NY (PRWEB) , ... May 27, 2016 , ... ... with Mediaplanet to help educate the many who are unaware of the plight ... to aphasia will run within the “Stroke Awareness” campaign. , The link between ...
(Date:5/27/2016)... ... May 27, 2016 , ... Aimed at nurses and employees ... which come courtesy of leaders in the nursing and health care industry. It also ... and associations—namely Abilene Christian University. , As the nursing industry is coming out ...
(Date:5/26/2016)... ... 2016 , ... Despite last week’s media reports hinting at a June rate ... until March 2017 for an interest rate increase, according to Rajeev Dhawan of the ... “The Federal Open Market Committee (FOMC) dot charts are of interest to the press ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... , May 27, 2016 According ... of hypertension is driving ambulatory blood pressure monitoring system ... elasticity and their ability to respond to different pressure ... condition can lead to various cardiovascular disorders such as ... disease. These diseases are growing in prevalence each year. ...
(Date:5/27/2016)... SAN FRANCISCO , May 27, 2016 ... biotechnology company focused on developing products for Regenerative Medicine, Neurology and ... Commissiong will be presenting at two upcoming investor conferences: ... Conference Center, 730 Third Avenue, New York City ... at 3:00pm Marcum MicroCap Conference   ...
(Date:5/26/2016)... 2016 A key trend that ... emergence of new treatments. Cardax, a development stage life ... The therapy is expected to fulfil large unmet medical ... conducting studies to develop new treatments for osteoarthritis. One ... involved in osteoarthritis are being investigated, and early trials ...
Breaking Medicine Technology: